Cite
HARVARD Citation
Dearnaley, D. et al. (n.d.). Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet oncology. 17 (8), pp. 1047-1060. [Online].